GlassScriptPhysician profile
Patton W Thompson
NPI 1851614028
$7,652.07
in general payments reported to CMS, 2019-2025
34 companies · $58.49 in 2025
The $58.49 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $715 · 2021: $553 · 2022: $1,248 · 2023: $4,090 · 2025: $58.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $658 · Travel and Lodging: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $658.46 |
| Travel and Lodging | $489.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,674.20 | 2022-2023 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $738.08 | 2019-2025 | Ofev, Stiolto Respimat |
| Glaxosmithkline, LLC. | $534.62 | 2019-2023 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $368.90 | 2019-2023 | Breztri |
| Genzyme Corporation | $289.16 | 2019-2023 | |
| Mylan Specialty L.P. | $235.50 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $218.98 | 2019-2023 | Dupixent |
| Ethicon INC. | $217.38 | 2022 | |
| Grifols USA, LLC | $197.83 | 2019-2023 | Prolastin-C Liquid |
| Genentech USA, INC. | $149.51 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $147.19 | 2019-2023 | Uptravi, Opsumit |
| Merck Sharp & Dohme LLC | $145.44 | 2019 | |
| United Therapeutics Corporation | $102.01 | 2022-2023 | Tyvaso |
| Janssen Pharmaceuticals, INC | $89.21 | 2019-2023 | Xarelto |
| Amgen INC. | $68.47 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $62.98 | 2022 | |
| Gilead Sciences, INC. | $43.75 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.03 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $36.01 | 2019 | |
| Astellas Pharma US INC | $31.21 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $28.71 | 2020 | |
| Noctrix Health, INC. | $27.81 | 2025 | Nidra |
| Jazz Pharmaceuticals INC. | $25.23 | 2022 | |
| Edwards Lifesciences Corporation | $24.98 | 2020 | |
| Electromed, INC. | $24.41 | 2021 | |
| Tactile Systems Technology INC | $20.43 | 2022 | |
| Insmed, INC. | $19.36 | 2023 | Arikayce |
| Circassia INC. | $18.35 | 2019 | |
| Allergan, INC. | $15.32 | 2019 | |
| Mayne Pharma Commercial LLC | $13.17 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.13 | 2022 | |
| Philips North America LLC | $12.51 | 2022 | |
| Shire North American Group INC | $11.80 | 2019 | |
| Inogen, INC. | $9.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patton Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.